EntryPoint Capital’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,338
Closed -$150K 1835
2023
Q4
$150K Buy
+6,338
New +$150K 0.14% 193